Hematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningStem Cell TransplantationHematopoietic Stem CellsGraft vs Host DiseaseHematologic NeoplasmsBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationTransplantation ChimeraMyeloablative AgonistsWhole-Body IrradiationTissue DonorsLiver TransplantationTreatment OutcomeGraft SurvivalHistocompatibility TestingBusulfanCord Blood Stem Cell TransplantationStem CellsHistocompatibilityVidarabineRecurrenceRetrospective StudiesMultiple MyelomaHematopoietic Stem Cell MobilizationGraft vs Tumor EffectUnrelated DonorsImmunosuppressive AgentsKidney TransplantationRemission InductionChimerismLeukemiaCombined Modality TherapyCell TransplantationAntigens, CD34HematopoiesisGraft vs Leukemia EffectSurvival AnalysisDisease-Free SurvivalMelphalanTransplantation ImmunologySurvival RateHLA AntigensLeukemia, Myeloid, AcuteSiblingsTime FactorsCyclophosphamideGraft RejectionMyelodysplastic SyndromesSalvage TherapyLymphoma, Non-HodgkinHeart TransplantationBone Marrow CellsHematologic DiseasesLymphocyte TransfusionFollow-Up StudiesMesenchymal Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsLung TransplantationDonor SelectionCell DifferentiationTransplantationHepatic Veno-Occlusive DiseaseGranulocyte Colony-Stimulating FactorImmunosuppressionAntilymphocyte SerumFlow CytometryOrgan TransplantationT-LymphocytesTransplantation, IsogeneicBone MarrowPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineAcute DiseaseMice, Inbred C57BLLymphocyte DepletionHodgkin DiseaseLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticLiving DonorsCytomegalovirus InfectionsSevere Combined ImmunodeficiencyColony-Forming Units AssayCell LineageFetal BloodAllograftsPrognosisCells, CulturedMinor Histocompatibility AntigensIslets of Langerhans TransplantationRisk FactorsCytarabineCarmustineBone Marrow PurgingLeukapheresisCell SeparationMycophenolic AcidLymphoma